Sign In

Jesse Baumgold

Senior Advisor at Adaptive Phage Therapeutics Inc

Jesse Baumgold is a seasoned entrepreneur with a successful track record of founding and selling two life science businesses.

He founded Receptor Biology, the first US company that supplied GPCR reagents to the drug discovery market, which was later acquired by Perkin Elmer Inc.

He also established Applied Cell Sciences, a company specializing in reagents and services for drug discovery, which was acquired by ChanTest Corp.

Jesse is known for his expertise in guiding new ventures in the life sciences industry, providing consulting services, engaging in angel investing, and driving technology commercialization.

His educational background includes a BA in Chemistry from Oberlin College and a Ph.D. in Neuroscience from the University of Rochester School of Medicine and Dentistry.

Throughout his career, Jesse has held key roles in various organizations such as Senior Advisor and COO at Adaptive Phage Therapeutics Inc, Founder & CEO at Applie Cell Sciences, Inc, General Manager at PerkinElmer, and many more.

His extensive experience covers areas like drug discovery, product development, business development, and strategic planning in the life science sector.

Highlights

May 11 · linkedin

Adaptive Phage Therapeutics raises a $ 40 million Series B to advance their PhageBank therapies for multi-drug resistant bacterial pathogens. See https://lnkd.in/df9hh9c

J
Add to my network

Location

Bethesda, Maryland, United States